WTAP has an important role in AML oncogenesis, which is a novel client protein of Hsp90.70 Thus, these works provide rationale for FTO/METTL3/METTL14/WTAP as potential therapeutic targets for AML treatment. This evidence concerns the gene METTL14 and acute myeloid leukemia.